Mirae Asset Global Investments
CSTL icon

Mirae Asset Global Investments’s Castle Biosciences CSTL Stock Holding History

Mirae Asset Global Investments’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.3K Sell
1,356
-195
-13% -$4.34K ﹤0.01% 1423
2026
Q1 		$38.1K Buy
1,551
+133
+9% +$4.36K ﹤0.01% 1343
2025
Q4 		$55.2K Buy
1,418
+297
+26% +$9.57K ﹤0.01% 1374
2025
Q3 		$25.5K Buy
1,121
+6
+0.5% +$122 ﹤0.01% 1460
2025
Q2 		$22.8K Buy
1,115
+183
+20% +$3.39K ﹤0.01% 1382
2025
Q1 		$18.6K Sell
932
-1
-0.1% -$25 ﹤0.01% 1396
2024
Q4 		$25K Sell
933
-70
-7% -$2.13K ﹤0.01% 1387
2024
Q3 		$27.9K Buy
1,003
+179
+22% +$4.56K ﹤0.01% 1388
2024
Q2 		$17.4K Sell
824
-10,908
-93% -$243K ﹤0.01% 1401
2024
Q1 		$260K Buy
11,732
+143
+1% +$3.11K ﹤0.01% 2167
2023
Q4 		$250K Buy
11,589
+42
+0.4% +$739 ﹤0.01% 2270
2023
Q3 		$195K Buy
11,547
+27
+0.2% +$472 ﹤0.01% 2309
2023
Q2 		$158K Sell
11,520
-53
-0.5% -$1.07K ﹤0.01% 2408
2023
Q1 		$263K Buy
11,573
+642
+6% +$15.7K ﹤0.01% 2227
2022
Q4 		$257K Buy
10,931
+11
+0.1% +$255 ﹤0.01% 2215
2022
Q3 		$285K Buy
+10,920
New +$306K ﹤0.01% 2186

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Mirae Asset Global Investments's CSTL Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Castle Biosciences (CSTL) stake by 13% in Q2 2026, selling an estimated $4.34K and leaving 1,356 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Mirae Asset Global Investments first reported a position in CSTL in Q3 2022 and has held it in 16 quarters since. The position peaked at $285K in Q3 2022. 61 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Mirae Asset Global Investments held 1,356 shares of Castle Biosciences worth $32.3K as of Q2 2026.
  • Mirae Asset Global Investments sold 195 Castle Biosciences shares in Q2 2026, an estimated $4.34K.
  • Castle Biosciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1423 holding.
  • Mirae Asset Global Investments first reported a position in Castle Biosciences in Q3 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Castle Biosciences position peaked at $285K in Q3 2022.
  • 61 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.